|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||29.95 / 50.05|
One way or another I continue to believe that some sort of tax legislation will be signed before the end of the year.
Jim Cramer is bullish on CVS Health, Coca-Cola, Norfolk Southern, IBM and Randgold Resources.
Jim Cramer says that whether it's at West Point or on Wall Street, leadership comes from loyalty, innovation, and the first-mover advantage.
Levi & Korsinsky announces it has commenced an investigation of Supernus Pharmaceuticals, Inc.
MediWound priced an underwritten public offering of 4.4 million shares at $5 apiece.
Federal Court Finds Supernus Patents Valid and Infringed by TWi
Here's a look at what Jim Cramer had to say about companies of interest to Mad Money viewers.
Investors need to focus on earnings and not be distracted by the circus in Washington, Jim Cramer says.
Oil prices are tumbling down. Bad news for companies and petro states, but great news at the pump and for these ten industries...
Anika focuses on pain management, tissue regeneration and wound healing.
The most recent short interest data has been released for the 03/31/2017 settlement date, which shows a 406,576 share increase in total short interest for Supernus Pharmaceuticals Inc , to 3,053,345, an increase of 15.36% since 03/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Trokendi XR is the Leading Extended-Release Topiramate Product and Brand of Topiramate
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.